ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Vitamin D for Sickle-cell Respiratory Complications

ClinicalTrials.gov ID: NCT01443728

Public ClinicalTrials.gov record NCT01443728. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01443728
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gary M Brittenham, MD
Other
Enrollment
70 participants

Conditions and interventions

Interventions

  • Active Comparator: Vitamin D3 12,000 IU Drug
  • Experimental: Vitamin D3 100,000 IU Drug

Drug

Eligibility (public fields only)

Age range
3 Years to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 12, 2011
Primary completion
Jun 19, 2013
Completion
Feb 14, 2015
Last update posted
Aug 8, 2024

2011 – 2015

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Columbia University Irving Medical Center New York New York 10032

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01443728, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2024 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01443728 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →